Has Basil Schaheen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,746 in general payments to Basil Schaheen, MD across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Basil Schaheen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Basil Schaheen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Basil Schaheen, MD

Plastic and Reconstructive Surgery · Gainesville, GANPI 1568728590

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.3% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 29.4% of the total.

$3,746in general payments, 2019–2025

Across 129 payments — averaging $29.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Integra Lifesciences Corporation$601
Smith+Nephew$423
Revance Therapeutics, Inc.$311
Polynovo North America LLC$296
Mentor Worldwide LLC$169
plus $844 from 17 others

What the payments were for

Food & beverage$3,42191%
Other$3269%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	51	$1,103
Integra Lifesciences Corporation	12	$601
Smith+Nephew	17	$423
Revance Therapeutics, Inc.	4	$311
Polynovo North America LLC	8	$296
Mentor Worldwide LLC	8	$169
Sanara Medtech Inc.	1	$141
Johnson & Johnson	3	$93
Bioventus LLC	2	$65
Kerecis Limited	2	$63
Axogen	2	$62
Lifenet Health	2	$53
RTI Surgical, Inc	2	$48
Acera Surgical, Inc.	2	$47
Access Pro Medical, LLC	1	$46
Davol Inc.	2	$45
TELA Bio, Inc.	2	$44
Kls-martin L.p.	1	$34
Vertex	1	$28
Aroa Biosurgery Incorporated	3	$25
Organogenesis Inc.	1	$24
Reprise Biomedical, Inc.	1	$14
Sonex Health, Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,746 in reported general payments places this provider in the 60th percentile of 83 plastic and reconstructive surgery providers in Georgia.

See all plastic and reconstructive surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$115,021

Medicare patients

189

Services billed

550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	74	$475
Gabapentin	65	$345
Silver Sulfadiazine	24	$327
Mupirocin	55	$299
Oxycodone Hcl	106	$177
Doxycycline Hyclate	33	$159
SsdSilver Sulfadiazine	12	$135
Ibuprofen	29	$116
Doxycycline Monohydrate	16	$109
Diazepam	16	$16
Tramadol Hcl	12	$8

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Gainesville

Rajiv SoodAugusta$502K
Carmen KavaliAtlanta$233K
Randal RuddermanAlpharetta$207K
James NamnoumAtlanta$97K
Michael MirzabeigiAtlanta$71K
Katherine SantosaAtlanta$65K
Marc YuneRoswell$64K
Asaf YalifAlpharetta$43K
Luther BakerColquitt$40K
Olumayowa AbiodunAlbany$35K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →